NCT06476535View on ClinicalTrials.gov

Observatory of Patients With MyeloProliferative Neoplasm Treated With Anti-inflammatory Immunotherapy

Active, not recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 11, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Myeloproliferative NeoplasmInflammatory Disease
Trial Locations (1)

29609

Chu Brest, Brest

All Listed Sponsors
lead

University Hospital, Brest

OTHER

NCT06476535 - Observatory of Patients With MyeloProliferative Neoplasm Treated With Anti-inflammatory Immunotherapy | Biotech Hunter | Biotech Hunter